• DOI:10.1080/14656566.2018.1515913
Corpus ID: 52099757

Non-vitamin-K oral anticoagulants (NOACs) for the prevention of secondary stroke

@article{Diener2018NonvitaminKOA,
  title={Non-vitamin-K oral anticoagulants (NOACs) for the prevention of secondary stroke},
  author={H. Diener and G. Ntaios and M. O'Donnell and J. Easton},
  journal={Expert Opinion on Pharmacotherapy},
  year={2018},
  volume={19},
  pages={1597 - 1602}
}

• H. Diener, G. Ntaios, +1 author J. Easton
• Published 2018
• Medicine
• Expert Opinion on Pharmacotherapy

ABSTRACT Introduction: In patients with atrial fibrillation (AF), oral anticoagulation with vitamin K antagonists (VKA) (warfarin, phenprocoumon) is effective both for primary and secondary stroke prevention with a 60–70% relative reduction in stroke risk compared with placebo. Mortality is reduced by 26%. VKA have a number of well-documented shortcomings which were overcome by non-vitamin-K oral anticoagulants (NOACs). Areas covered: Results of randomized trials for four NOACs (apixaban… Expand

View on Taylor & Francis

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed